Case Reports
doi: 10.1016/s0924-9338(02)00641-7.
Switching to amisulpride due to hepatic complications
Affiliations
- PMID: 12052579
- DOI: 10.1016/s0924-9338(02)00641-7
Item in Clipboard
Case Reports
Switching to amisulpride due to hepatic complications
Eur Psychiatry.
2002 May.
No abstract available
Similar articles
-
Amisulpride compared with standard neuroleptics in acute exacerbations of schizophrenia: three efficacy studies.Int Clin Psychopharmacol. 1997 May;12 Suppl 2:S11-7. doi: 10.1097/00004850-199705002-00004. Int Clin Psychopharmacol. 1997. PMID: 9218163 Review.
-
Amisulpride: a review of its efficacy in schizophrenia.Acta Psychiatr Scand Suppl. 2000;400:17-22. Acta Psychiatr Scand Suppl. 2000. PMID: 10823307 Review.
-
Clinical advantages of amisulpride in the treatment of acute schizophrenia.J Int Med Res. 2001 Nov-Dec;29(6):451-66. doi: 10.1177/147323000102900601. J Int Med Res. 2001. PMID: 11803729 Clinical Trial.
-
Safety profile of amisulpride in short- and long-term use.Acta Psychiatr Scand Suppl. 2000;400:23-7. doi: 10.1111/j.0065-1591.2000.007s021[dash]5.x. Acta Psychiatr Scand Suppl. 2000. PMID: 10823308 Review.
-
Long-term safety and efficacy of amisulpride in subchronic or chronic schizophrenia. Amisulpride Study Group.Int Clin Psychopharmacol. 2000 Jan;15(1):13-22. doi: 10.1097/00004850-200015010-00002. Int Clin Psychopharmacol. 2000. PMID: 10836281 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
